Compare $NPCE vs $OFIX | Chartloom

Compare

$NPCE vs $OFIX

Neuropace Inc · Orthofix Medical Inc

NPCE

Neuropace Inc

OFIX

Orthofix Medical Inc

Compare $NPCE vs $OFIX

Comparing Neuropace Inc and Orthofix Medical Inc

NPCENeuropace Inc

OFIXOrthofix Medical Inc

NPCENeuropace Inc

Market cap

$432M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

3.83x

Rev growth (TTM)

11.6%

YTD performance

-16.5%

52W performance

13.8%

FCF yield

-2.7%

OFIXOrthofix Medical Inc

Market cap

$371M

P/E (TTM)

—

Forward P/E (NTM)

—

Forward P/S (NTM)

0.42x

Rev growth (TTM)

3.0%

YTD performance

-38.2%

52W performance

-36.2%

FCF yield

-7.5%

Add ticker

Add up to 1 more ticker to compare

Relative performance

Each ticker starts at 100. 110 means +10% from the start of this window — not a $110 share price.

NPCE

OFIX

Detailed metrics comparison

NPCE

Neuropace Inc

OFIX

Orthofix Medical Inc

Market Cap

NPCE$432M

OFIX$371M

Enterprise Value

NPCE$478M

OFIX$501M

Price

NPCE$12.67

OFIX$9.17

P/E Ratio

NPCEN/A

OFIXN/A

P/S Ratio

NPCE4.37x

OFIX0.44x

EV/Sales

NPCE4.84x

OFIX0.60x

EV/EBITDA

NPCE0.00x

OFIX36.70x

P/B Ratio

NPCE36.68x

OFIX0.86x

P/FCF Ratio

NPCEN/A

OFIXN/A

EV/FCF

NPCE-41.21x

OFIX-18.02x

PEG Ratio

NPCEN/A

OFIXN/A

Forward P/E (NTM)

NPCEN/A

OFIXN/A

Forward P/S (NTM)

NPCE3.83x

OFIX0.42x

Revenue (TTM)

NPCE$99M

OFIX$833M

Revenue Growth (YoY)

NPCE11.6%

OFIX3.0%

Forward Rev Growth

NPCE22.0%

OFIX2.5%

Gross Margin (TTM)

NPCE79.6%

OFIX71.3%

Operating Margin (TTM)

NPCE0.0%

OFIX0.0%

EBITDA Margin (TTM)

NPCE-15.0%

OFIX1.6%

Net Margin (TTM)

NPCE-19.3%

OFIX-7.4%

FCF Margin (TTM)

NPCE-11.7%

OFIX-3.3%

Net Income (TTM)

NPCE$-19M

OFIX$-62M

FCF (TTM)

NPCE$-12M

OFIX$-28M

EPS (TTM)

NPCE-$0.56

OFIX-$1.51

ROE (TTM)

NPCE-11968.0%

OFIX-1405.0%

ROA (TTM)

NPCE-1871.0%

OFIX-717.0%

ROIC (TTM)

NPCE-2552.0%

OFIX-958.0%

Cash

NPCE$13M

OFIX$104M

Debt

NPCE$59M

OFIX$235M

Net Cash/Debt

NPCE$-46M

OFIX$-131M

Current Ratio (TTM)

NPCE4.94x

OFIX2.84x

Quick Ratio (TTM)

NPCE3.82x

OFIX1.53x

Debt/Equity (TTM)

NPCE4.97x

OFIX0.55x

Debt/Assets (TTM)

NPCE0.0%

OFIX0.0%

Interest Coverage (TTM)

NPCEN/A

OFIXN/A

Net Debt/EBITDA (TTM)

NPCE0.00x

OFIX0.00x

Beta

NPCE1.95

OFIX0.66

52W Performance

NPCE13.8%

OFIX-36.2%

YTD Performance

NPCE-16.5%

OFIX-38.2%

% from 52W High

NPCE-35.4%

OFIX-46.0%

% from 52W Low

NPCE37.4%

OFIX7.9%

Asset Turnover (TTM)

NPCE0.97x

OFIX0.97x

FCF Yield (TTM)

NPCE-2.7%

OFIX-7.5%

Earnings Yield (TTM)

NPCE-4.4%

OFIX-16.7%

Dividend Yield (TTM)

NPCEN/A

OFIXN/A

Rule of 40

NPCE-0.2

OFIX-0.4

EV/GP/RG

NPCE0.40

OFIX0.14

Ticker research

View NPCE research View OFIX research

Metric	NPCE Neuropace Inc	OFIX Orthofix Medical Inc
Market & Valuation
Market Cap	$432M	$371M
Enterprise Value	$478M	$501M
Price	$12.67	$9.17
P/E Ratio	N/A	N/A
P/S Ratio	4.37x	0.44x
EV/Sales	4.84x	0.60x
EV/EBITDA	0.00x	36.70x
P/B Ratio	36.68x	0.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.21x	-18.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	0.42x
Revenue & Growth
Revenue (TTM)	$99M	$833M
Revenue Growth (YoY)	11.6%	3.0%
Forward Rev Growth	22.0%	2.5%
Profitability
Gross Margin (TTM)	79.6%	71.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-15.0%	1.6%
Net Margin (TTM)	-19.3%	-7.4%
FCF Margin (TTM)	-11.7%	-3.3%
Net Income (TTM)	$-19M	$-62M
FCF (TTM)	$-12M	$-28M
EPS (TTM)	-$0.56	-$1.51
ROE (TTM)	-11968.0%	-1405.0%
ROA (TTM)	-1871.0%	-717.0%
ROIC (TTM)	-2552.0%	-958.0%
Financial Health
Cash	$13M	$104M
Debt	$59M	$235M
Net Cash/Debt	$-46M	$-131M
Current Ratio (TTM)	4.94x	2.84x
Quick Ratio (TTM)	3.82x	1.53x
Debt/Equity (TTM)	4.97x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.66
52W Performance	13.8%	-36.2%
YTD Performance	-16.5%	-38.2%
% from 52W High	-35.4%	-46.0%
% from 52W Low	37.4%	7.9%
Efficiency & Yields
Asset Turnover (TTM)	0.97x	0.97x
FCF Yield (TTM)	-2.7%	-7.5%
Earnings Yield (TTM)	-4.4%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.2	-0.4
EV/GP/RG	0.40	0.14
Ticker research	View NPCE research	View OFIX research

Valuation

P/S Ratio

OFIX

0.44x

NPCE

4.37x

EV/FCF

NPCE

-41.21x

OFIX

-18.02x

Growth & revenue

Revenue Growth TTM

NPCE

11.6%

OFIX

3.0%

Forward Revenue Growth

NPCE

22.0%

OFIX

2.5%

Profitability & performance

Gross Margin

NPCE

79.6%

OFIX

71.3%

ROE

OFIX

-1405.0%

NPCE

-11968.0%

FCF Yield %

NPCE

-2.7%

OFIX

-7.5%

52-Week Performance

NPCE

13.8%

OFIX

-36.2%

Detailed metrics comparison

NPCE

Neuropace Inc

OFIX

Orthofix Medical Inc

Market Cap

NPCE$432M

OFIX$371M

Enterprise Value

NPCE$478M

OFIX$501M

Price

NPCE$12.67

OFIX$9.17

P/E Ratio

NPCEN/A

OFIXN/A

P/S Ratio

NPCE4.37x

OFIX0.44x

EV/Sales

NPCE4.84x

OFIX0.60x

EV/EBITDA

NPCE0.00x

OFIX36.70x

P/B Ratio

NPCE36.68x

OFIX0.86x

P/FCF Ratio

NPCEN/A

OFIXN/A

EV/FCF

NPCE-41.21x

OFIX-18.02x

PEG Ratio

NPCEN/A

OFIXN/A

Forward P/E (NTM)

NPCEN/A

OFIXN/A

Forward P/S (NTM)

NPCE3.83x

OFIX0.42x

Revenue (TTM)

NPCE$99M

OFIX$833M

Revenue Growth (YoY)

NPCE11.6%

OFIX3.0%

Forward Rev Growth

NPCE22.0%

OFIX2.5%

Gross Margin (TTM)

NPCE79.6%

OFIX71.3%

Operating Margin (TTM)

NPCE0.0%

OFIX0.0%

EBITDA Margin (TTM)

NPCE-15.0%

OFIX1.6%

Net Margin (TTM)

NPCE-19.3%

OFIX-7.4%

FCF Margin (TTM)

NPCE-11.7%

OFIX-3.3%

Net Income (TTM)

NPCE$-19M

OFIX$-62M

FCF (TTM)

NPCE$-12M

OFIX$-28M

EPS (TTM)

NPCE-$0.56

OFIX-$1.51

ROE (TTM)

NPCE-11968.0%

OFIX-1405.0%

ROA (TTM)

NPCE-1871.0%

OFIX-717.0%

ROIC (TTM)

NPCE-2552.0%

OFIX-958.0%

Cash

NPCE$13M

OFIX$104M

Debt

NPCE$59M

OFIX$235M

Net Cash/Debt

NPCE$-46M

OFIX$-131M

Current Ratio (TTM)

NPCE4.94x

OFIX2.84x

Quick Ratio (TTM)

NPCE3.82x

OFIX1.53x

Debt/Equity (TTM)

NPCE4.97x

OFIX0.55x

Debt/Assets (TTM)

NPCE0.0%

OFIX0.0%

Interest Coverage (TTM)

NPCEN/A

OFIXN/A

Net Debt/EBITDA (TTM)

NPCE0.00x

OFIX0.00x

Beta

NPCE1.95

OFIX0.66

52W Performance

NPCE13.8%

OFIX-36.2%

YTD Performance

NPCE-16.5%

OFIX-38.2%

% from 52W High

NPCE-35.4%

OFIX-46.0%

% from 52W Low

NPCE37.4%

OFIX7.9%

Asset Turnover (TTM)

NPCE0.97x

OFIX0.97x

FCF Yield (TTM)

NPCE-2.7%

OFIX-7.5%

Earnings Yield (TTM)

NPCE-4.4%

OFIX-16.7%

Dividend Yield (TTM)

NPCEN/A

OFIXN/A

Rule of 40

NPCE-0.2

OFIX-0.4

EV/GP/RG

NPCE0.40

OFIX0.14

Ticker research

View NPCE research View OFIX research

Metric	NPCE Neuropace Inc	OFIX Orthofix Medical Inc
Market & Valuation
Market Cap	$432M	$371M
Enterprise Value	$478M	$501M
Price	$12.67	$9.17
P/E Ratio	N/A	N/A
P/S Ratio	4.37x	0.44x
EV/Sales	4.84x	0.60x
EV/EBITDA	0.00x	36.70x
P/B Ratio	36.68x	0.86x
P/FCF Ratio	N/A	N/A
EV/FCF	-41.21x	-18.02x
PEG Ratio	N/A	N/A
Forward P/E (NTM)	N/A	N/A
Forward P/S (NTM)	3.83x	0.42x
Revenue & Growth
Revenue (TTM)	$99M	$833M
Revenue Growth (YoY)	11.6%	3.0%
Forward Rev Growth	22.0%	2.5%
Profitability
Gross Margin (TTM)	79.6%	71.3%
Operating Margin (TTM)	0.0%	0.0%
EBITDA Margin (TTM)	-15.0%	1.6%
Net Margin (TTM)	-19.3%	-7.4%
FCF Margin (TTM)	-11.7%	-3.3%
Net Income (TTM)	$-19M	$-62M
FCF (TTM)	$-12M	$-28M
EPS (TTM)	-$0.56	-$1.51
ROE (TTM)	-11968.0%	-1405.0%
ROA (TTM)	-1871.0%	-717.0%
ROIC (TTM)	-2552.0%	-958.0%
Financial Health
Cash	$13M	$104M
Debt	$59M	$235M
Net Cash/Debt	$-46M	$-131M
Current Ratio (TTM)	4.94x	2.84x
Quick Ratio (TTM)	3.82x	1.53x
Debt/Equity (TTM)	4.97x	0.55x
Debt/Assets (TTM)	0.0%	0.0%
Interest Coverage (TTM)	N/A	N/A
Net Debt/EBITDA (TTM)	0.00x	0.00x
Performance
Beta	1.95	0.66
52W Performance	13.8%	-36.2%
YTD Performance	-16.5%	-38.2%
% from 52W High	-35.4%	-46.0%
% from 52W Low	37.4%	7.9%
Efficiency & Yields
Asset Turnover (TTM)	0.97x	0.97x
FCF Yield (TTM)	-2.7%	-7.5%
Earnings Yield (TTM)	-4.4%	-16.7%
Dividend Yield (TTM)	N/A	N/A
Other
Rule of 40	-0.2	-0.4
EV/GP/RG	0.40	0.14
Ticker research	View NPCE research	View OFIX research